Midomit 150mg Injection
Marketer
Mits Healthcare Pvt Ltd
Salt Composition
Amiodarone (150mg)
Overview Midomit 150mg Injection
CardioRhythm 150mg Injection effectively manages diverse severe cardiac rhythm disorders, including atrial fibrillation and rapid heart rates (tachycardia). This anti-arrhythmic medication swiftly reinstates a normal, consistent heartbeat. Administered intravenously via slow infusion under strict medical supervision, continuous heart rate and blood pressure monitoring is essential. Treatment should continue as directed by your physician; premature cessation may result in life-threatening arrhythmias. Following intravenous therapy, oral medication may be prescribed. Common side effects include low blood pressure (hypotension), slow heart rate (bradycardia), visual disturbances, and injection site reactions (pain, itching, redness). Rarely, liver, lung, neurological, or thyroid complications may occur. Promptly report any unusual symptoms to your doctor. Complete clearance of this medication from the body is prolonged, potentially leading to lingering side effects post-treatment. Consult your doctor regarding preventative or mitigative strategies.
Uses of Midomit 150mg Injection
Irregular heartbeat
Major Benefits of Midomit 150mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Midomit 150mg Injection:
- Decreased blood pressure
- Slow heart rate
- Blurred vision
- Application site reactions (burning, irritation, itching and redness)
How to use Midomit 150mg Injection:
This medication will be administered by your physician or their registered nurse. Self-medication is strictly prohibited.
How Midomit 150mg Injection works:
Rhythmo-control 150mg injection is an antiarrhythmic agent that normalizes cardiac rhythm by suppressing erratic electrical impulses within the heart.
SAFETY ADVICE
AlcoholCAUTION
Use of Midomit 150mg Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Midomit 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administering Midomit 150mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Following administration of Midomit 150mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneySAFE IF PRESCRIBED
Midomit 150mg Injection poses no safety concerns for individuals with kidney impairment; dosage modification isn't necessary. Nevertheless, disclosure of pre-existing kidney disease to your physician is advised.
LiverCAUTION
Exercise caution when administering Midomit 150mg Injection to individuals with liver impairment; dosage modification may be necessary. Hepatic damage is a potential adverse effect of Midomit 150mg Injection, necessitating potential dose adjustments. Physician consultation is advised.
What if you forget to take Midomit 150mg Injection :
NA
Facts to Know About Midomit 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzofuran-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Class III Antiarrhythmic Agents |
3,018 People bought this recently